Issue 12/2019
Content (13 Articles)
Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer—a meta-analysis
Jan Haussmann, Bálint Tamaskovics, Edwin Bölke, Freddy-Joel Djiepmo-Njanang, Kai Kammers, Stefanie Corradini, Matthias Hautmann, Pirus Ghadjar, Kitti Maas, Patrick J. Schuler, Thomas K. Hoffmann, Guido Lammering, Wilfried Budach, Christiane Matuschek
Outcome and management of rare high-grade “salivary” adenocarcinoma: the important role of adjuvant (chemo)radiotherapy
Claudia Scherl, Marlen Haderlein, Abbas Agaimy, Konstantinos Mantsopoulos, Michael Koch, Maximilian Traxdorf, Rainer Fietkau, Philipp Grundtner, Heinrich Iro
Re-irradiation for osteoarthritis—retrospective analysis of 217 joints
Matthias G. Hautmann, Philipp Rechner, Matthias Hipp, Ulrich Neumaier, Felix Steger, Fabian Pohl, Markus Weber, Oliver Kölbl, Christoph Süß
Radiotherapy for painful benign skeletal disorders
Nderim Juniku, Oliver Micke, M. Heinrich Seegenschmiedt, Ralph Muecke
Stability and survival analysis of elderly patients with osteolytic spinal bone metastases after palliative radiotherapy
Tilman Bostel, Robert Förster, Ingmar Schlampp, Tanja Sprave, Sati Akbaba, Daniel Wollschläger, Jürgen Debus, Arnulf Mayer, Heinz Schmidberger, Harald Rief, Nils Henrik Nicolay
Radiotherapy of patients with cardiac implantable electronic devices according to the DEGRO/DGK guideline—is the risk of relevant errors overestimated?
Felix Steger, Matthias G. Hautmann, Christoph Süß, Ute Hubauer, Ekrem Ücer, Lars Maier, Oliver Kölbl, Carsten Jungbauer
Automatic image segmentation based on synthetic tissue model for delineating organs at risk in spinal metastasis treatment planning
Olaf Wittenstein, Patrick Hiepe, Lars Henrik Sowa, Elias Karsten, Iris Fandrich, Juergen Dunst
Successful integration of radiation oncology in preclinical medical education
Michael Oertel, Martina Schmitz, Jan Carl Becker, Hans Theodor Eich, Anna Schober
Dosis-Deeskalation der adjuvanten Radiochemotherapie bei HPV-positiven Oropharynxkarzinomen: die MC1273-Phase-II-Studie
Alexander Rühle, Nils H. Nicolay
Lokal konsolidierende Strahlentherapie beim oligometastasierten Nicht-kleinzelligen Bronchialkarzinom
Alexander Fabian, Florian Pyschny, David Krug
Extreme Hypofraktionierung beim lokalisierten Prostatakarzinom. 5-Jahresergebnisse der HYPO-RT-PC-Studie: Kommentar I
Ping Jiang, Oliver Blanck, Jürgen Dunst
Extreme Hypofraktionierung beim lokalisierten Prostatakarzinom. 5-Jahresergebnisse der HYPO-RT-PC-Studie: Kommentar II
Gregor Goldner